Skip to Main Content

In the United States, pharmaceutical advertising seems inescapable.

Since the first prescription drug ad ran in the early 1980s, the business of pharmaceutical advertising has exploded. Drug companies spent $7 billion on advertising last year, according to Statista, with most of that going to television ads; more than $287 million was spent on TV advertising for Sanofi and Regeneron’s anti-inflammatory drug Dupixent alone.

advertisement

Yet most people would rather not see these ads at all. In a 2016 STAT-Harvard T.H. Chan poll, more than half of the people surveyed — 57%, to be precise — wanted drug ads to be taken off the air.

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect

To submit a correction request, please visit our Contact Us page.